Abiomed (ABMD) Income Statement

Click line-items for a historical chart and %

Products	102.93M
Funded research and development	27K
Revenues, Total	102.96M
Cost of product revenue excluding amortization of intangibles	17.31M
Research and development	18.05M
Selling, general and administrative	53.09M
Amortization of intangible assets
Costs and Expenses, Total	88.45M
Loss from operations	14.51M
Investment income (expense), net	342K
Gain on sale of WorldHeart stock
Other (expense) income, net	-114K
Nonoperating Income (Expense), Total	228K
Loss before provision for income taxes
Provision for income taxes	5.86M
Net loss	8.88M
Basic and diluted net loss per share
Weighted average shares outstanding

Entities mentioned with ABMD

View All Entities